Inventor
KUNO ATSUSHI
JP26 patents
⚠️ This page may combine multiple inventors who share the name “KUNO ATSUSHI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
FUJISAWA PHARMACEUTICAL CO
11 patentsUS5622976AApr 22, 1997
Oxadiazole derivatives having acetylcholinesterase-inhibitory and muscarinic agonist activity
FUJISAWA PHARMACEUTICAL CO28 citations92
US5824691AOct 20, 1998
Guanidine derivatives as inhibitors of Na+ /H+ exchange in cells
FUJISAWA PHARMACEUTICAL CO32 citations91
US4698340AOct 6, 1987
Pyrimidine derivatives, processes for preparation thereof and composition containing the same
FUJISAWA PHARMACEUTICAL CO23 citations81
US5059608AOct 22, 1991
Bicyclic amine compound and a process for the preparation thereof
FUJISAWA PHARMACEUTICAL CO14 citations74
US5037824AAug 6, 1991
N-containing heterocyclic compounds, compositions and use
FUJISAWA PHARMACEUTICAL CO10 citations73
US4931453AJun 5, 1990
Di phenylpyridazine compounds, processes for the preparation thereof and pharmaceutical compositions comprising the same
FUJISAWA PHARMACEUTICAL CO6 citations73
US4831030AMay 16, 1989
Diphenylpyridine compounds, processes for the preparation thereof and composition comprising the same
FUJISAWA PHARMACEUTICAL CO8 citations73
US4727073AFeb 23, 1988
Pyrimidine derivatives and composition of the same
FUJISAWA PHARMACEUTICAL CO14 citations73
US4990507AFeb 5, 1991
N-containing heterocyclic compounds, and composition comprising the same
FUJISAWA PHARMACEUTICAL CO8 citations71
US4857527AAug 15, 1989
Morpholine containing pyridine compounds, compositions and use
FUJISAWA PHARMACEUTICAL CO12 citations71
US5968985AOct 19, 1999
Benzoylguanidine derivatives as medicaments
FUJISAWA PHARMACEUTICAL CO6 citations61
AIST
4 patentsUS11571473B2Feb 7, 2023
Method for efficiently inducing antibody, antibody and detection system for hepatitis virus
AIST1 citations56
US10539576B2Jan 21, 2020
Lung cancer differential marker
AIST0 citations47
US10156576B2Dec 18, 2018
Method for enrichment and separation of spinal fluid glycoprotein, method for searching for marker for central nervous system diseases which utilizes the aforementioned method, and marker for central nervous system diseases
AIST0 citations36
US10352927B2Jul 16, 2019
Glycoform detection method and glycoform detection device
AIST0 citations34
NARIMATSU HISASHI
3 patentsUS9696320B2Jul 4, 2017
Lung cancer differential marker
NARIMATSU HISASHI3 citations67
US9796761B2Oct 24, 2017
Glycan markers as measure of disease state of hepatic diseases
NARIMATSU HISASHI3 citations66
US8623608B2Jan 7, 2014
Method for measuring glycoprotein, method for examining liver disease, reagent for quantitative determination of glycoprotein, and glycan-marker glycoprotein as an index for clinical conditions of liver disease
NARIMATSU HISASHI3 citations58